Reducing Hospital-Acquired Infections: The Key to Patient Safety
Image Source: FreeImages
## Introduction
In the midst of the ongoing COVID-19 pandemic, it is crucial not to overlook the presence of other infections and outbreaks caused by various microorganisms. While the world’s attention and resources are rightfully focused on combating COVID-19, it is important to recognize that other pathogens can still pose a significant risk. Hospital-acquired infections, also known as healthcare-associated infections (HAI or HCAI), are a prime example of these persistent threats. However, the continuous efforts to improve infection control practices, driven by the current pandemic, may actually have a positive impact on reducing the rates of other nosocomial infections.
The Scope of Hospital-Acquired Infections
Hospital-acquired infections refer to infections that are acquired during a hospital stay and typically manifest 48 hours after admission. According to the National Institute of Health and Care Excellence (NICE), an estimated 300,000 people in England alone are diagnosed with HCAIs each year, resulting in a staggering cost of £1 billion for the National Health Service (NHS). These infections can be caused by a variety of factors, including contaminated equipment and materials, as well as cross-contamination within the hospital environment.
Respiratory Tract Infections (Pneumonia)
Pneumonia, an infection of the lung tissue, is a common condition that affects 8 in 1,000 people annually in the UK. Hospital-acquired pneumonia, a subtype of pneumonia, is estimated to affect 0.5% to 1.0% of hospitalized patients and is the leading cause of healthcare-associated infection-related deaths. Methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and other non-pseudomonal Gram-negative bacteria are the primary culprits behind hospital-acquired pneumonia. This infection can significantly prolong hospital stays by approximately 8 days and has a reported mortality rate ranging from 30% to 70%.
Surgical Site Infections
Surgical site infections (SSIs) account for up to 20% of all healthcare-associated infections and affect at least 5% of patients who undergo surgical procedures. These infections can range from minor wound discharge within 7 to 10 days of an operation to life-threatening complications. Enterobacterales, including Escherichia coli, Klebsiella, Salmonella, and Shigella, are the most common causative organisms for both superficial and deep SSIs. S. aureus also contributes significantly to deep or organ space SSIs. The incidence of SSIs varies depending on the surgical procedure, with knee replacement and large bowel surgery being particularly susceptible.
Sepsis/Bacteraemia
Sepsis, a clinical syndrome triggered by the presence of an infection, is a leading cause of death among hospitalized patients in the intensive care unit (ICU). The most common causes of sepsis in adults include pneumonia, bowel perforation, urinary tract infection, and severe skin infection. The UK Sepsis Trust estimates that 37,000 people die from sepsis in the UK annually. Globally, diarrheal diseases and lower respiratory infections account for a significant number of sepsis cases and sepsis-related mortality. However, an increasing number of cases are now associated with non-communicable diseases, such as underlying injuries or chronic diseases.
Clostridium Difficile Infections (CDIs)
Clostridium difficile (C.diff) is recognized as the leading cause of healthcare-associated infective diarrhea, and its prevalence is on the rise in both healthcare and community settings. C.diff can be found in the intestinal tracts of healthy individuals and is highly resistant to disinfection. The first European Centre for Disease Prevention and Control (ECDC) point-prevalence survey estimated that approximately 124,000 patients develop healthcare-associated CDI within the European Union each year. The primary mediators of inflammation in CDI are large clostridial toxins, which trigger a cascade of host cellular responses, leading to symptoms such as diarrhea, inflammation, and tissue necrosis.
Urinary Tract Infections
Urinary tract infections (UTIs) are caused by the presence and multiplication of microorganisms in the urinary tract. These infections can result in various clinical syndromes, including acute and chronic pyelonephritis, cystitis, urethritis, epididymitis, and prostatitis. Uncomplicated UTIs primarily affect women, children, and healthy elderly individuals, while complicated UTIs are associated with factors such as indwelling catheters, urinary tract abnormalities, immunosuppression, or previous exposure to antibiotics. Uropathogenic Escherichia coli (UPEC) is the most common causative agent for both uncomplicated and complicated UTIs, followed by other pathogens such as Klebsiella pneumoniae and Staphylococcus saprophyticus.
The Importance of Infection Control and Prevention
To reduce the rates of hospital-acquired infections, implementing effective infection control and prevention measures is crucial. Adherence to cleaning protocols, hand hygiene practices, and the use of alternative interventions such as automated disinfection technologies are essential. Manual cleaning alone is not sufficient to eliminate contamination at a safe level for patients and staff. The integration of automated no-touch technologies, such as UV-C light and hydrogen peroxide vapor, alongside manual cleaning, has shown promising results in improving outcomes and reducing infection rates.
The Role of Preventive Bundles
Preventive bundles are comprehensive sets of evidence-based practices designed to prevent specific healthcare-associated infections. These bundles include a combination of interventions such as hand hygiene, proper disinfection practices, antimicrobial stewardship, and patient education. The implementation of preventive bundles has been shown to significantly reduce the incidence of hospital-acquired infections, including SSIs and UTIs. Healthcare facilities should prioritize the adoption of preventive bundles as part of their infection control strategies.
The Future of Infection Control
In the face of ongoing challenges posed by hospital-acquired infections, continuous research and development are crucial. Prioritizing the discovery and development of new antibiotics to combat multidrug-resistant pathogens, such as MRSA and C.diff, is essential. Additionally, ongoing education and training for healthcare professionals on infection control practices and the proper use of disinfection technologies are vital to ensuring patient safety.
Conclusion
Reducing hospital-acquired infections is of paramount importance in providing safe and effective healthcare. While the COVID-19 pandemic has understandably dominated the healthcare landscape, it is crucial not to overlook the ongoing threat of other infections. By implementing rigorous infection control measures, including the use of preventive bundles and automated disinfection technologies, healthcare facilities can significantly reduce the rates of hospital-acquired infections. Continued research, education, and innovation in infection control will be essential in safeguarding patient well-being and improving overall healthcare outcomes.
